IDH2 and central nervous system cancer: IDH1R132H, the most common form in glioma, produces the least amount of D-2HG and correlates with worse survival compared with the rare IDH1R132X and IDH2-R172 mutations, which produce higher levels of D-2HG [12,33,39].